论文部分内容阅读
高脂血症是导致肾小球疾病患者向肾小球硬化进展的重要因素。饮食控制及口服药物有时不能有效控制症状 ,本文介绍近几年来广泛应用于临床的选择性LDL体外分离法 (LDL A) ,包括生物亲和性和物理化学亲和性吸附剂的原理、步骤、特点及不良反应。与传统方法相比较 ,LDL A疗效确切、操作简单、不良反应少 ,是一新的治疗肾小球疾病患者高脂血症的可靠手段
Hyperlipidemia is an important factor in the progression of glomerulosclerosis in patients with glomerular diseases. Diet control and oral medication sometimes can not effectively control the symptoms. This article describes the widely used in recent years, clinical selective LDL in vitro isolation (LDL A), including biocompatibility and physicochemical affinity adsorbent principles, steps, Features and adverse reactions. Compared with the traditional methods, LDL A curative effect is accurate, simple operation, fewer adverse reactions, is a new reliable treatment of patients with glomerular disease, a reliable means of hyperlipidemia